PCP4 regulates Purkinje cell excitability and cardiac rhythmicity

Journal of Clinical Investigation

Volumn 124, Issue 11, 2014, Pages 5027-5036

  Kim, Eugene E ^a   Shekhar, Akshay ^a   Lu, Jia ^a   Lin, Xianming ^a   Liu, Fang Yu ^a   Zhang, Jie ^a   Delmar, Mario ^a   Fishman, Glenn I ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALMODULIN; CELL PROTEIN; PURKINJE CELL PROTEIN 4; UNCLASSIFIED DRUG; NERVE PROTEIN; PCP4 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HEART MUSCLE EXCITABILITY; HEART RHYTHM; IN VIVO STUDY; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; PROTEIN EXPRESSION; PURKINJE CELL; PURKINJE FIBER; 129 MOUSE; ANIMAL; C57BL MOUSE; CALCIUM SIGNALING; GENE EXPRESSION; HEART CONTRACTION; HUMAN; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; CALCIUM SIGNALING; GENE EXPRESSION; HUMANS; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; NERVE TISSUE PROTEINS; PURKINJE FIBERS;

EID: 84908611353     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI77495     Document Type: Article

References (38)

1. Haissaguerre M, et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation. 2003;108(8):925-928.
2. Kang G, et al. Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy. Circ Res. 2010;107(4):512-519.
3. Bansch D, et al. Successful catheter ablation of electrical storm after myocardial infarction. Circulation. 2003;108(24):3011-3016.
4. Sinha AM, et al. Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy. Pacing Clin Electrophysiol. 2009;32(3):286-290.
5. Boyden PA, Hirose M, Dun W. Cardiac Purkinje cells. Heart Rhythm. 2010;7(1):127-135.
6. Ideker RE, Kong W, Pogwizd S. Purkinje fibers and arrhythmias. Pacing Clin Electrophysiol. 2009;32(3):283-285.
7. Di Maio A, Ter Keurs HE, Franzini-Armstrong C. T-tubule profiles in Purkinje fibres of mammalian myocardium. J Muscle Res Cell Motil. 2007;28(2-3):115-121.
8. 2+ window current. Circ Res. 1992;70(3):456-464.
9. 2+ release events generated by an interaction between ryanodine and IP3 receptors in canine Purkinje cells. J Mol Cell Cardiol. 2008;45(2):176-184.
10. Vassalle M, Lin CI. Calcium overload and cardiac function. J Biomed Sci. 2004;11(5):542-565.
11. Cordeiro JM, Spitzer KW, Giles WR. Repolarizing K+ currents in rabbit heart Purkinje cells. J Physiol. 1998;508(pt 3):811-823.
12. Vaidyanathan R, et al. The ionic bases of the action potential in isolated mouse cardiac Purkinje cell. Heart Rhythm. 2013;10(1):80-87.
13. Pallante BA, et al. Contactin-2 expression in the cardiac Purkinje fiber network. Circ Arrhythm Electrophysiol. 2010;3(2):186-194.
14. Li P, Rudy Y. A model of canine purkinje cell electrophysiology and Ca(2+) cycling: rate dependence, triggered activity, and comparison to ventricular myocytes. Circ Res. 2011;109(1):71-79.
15. Slemmon JR, Morgan JI, Fullerton SM, Danho W, Hilbush BS, Wengenack TM. Camstatins are peptide antagonists of calmodulin based upon a conserved structural motif in PEP-19, neurogranin, and neuromodulin. J Biol Chem. 1996;271(27):15911-15917.
16. Kleerekoper QK, Putkey JA. PEP-19, an intrinsically disordered regulator of calmodulin signaling. J Biol Chem. 2009;284(12):7455-7464.
17. Johanson RA, Sarau HM, Foley JJ, Slemmon JR. Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II In situ. J Neurosci. 2000;20(8):2860-2866.
18. Saimi Y, Kung C. Calmodulin as an ion channel subunit. Annu Rev Physiol. 2002;64:289-311.
19. Swaminathan PD, Purohit A, Hund TJ, Anderson ME. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ Res. 2012;110(12):1661-1677.
20. Crotti L, et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 2013;127(9):1009-1017.
21. Nyegaard M, et al. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet. 2012;91(4):703-712.
22. Janiak R, Lewartowski B. Early after-depolarisations induced by noradrenaline may be initiated by calcium released from sarcoplasmic reticulum. Mol Cell Biochem. 1996;163-164:125-130.
23. 2+ waves, afterdepolarizations, and triggered arrhythmias. Cardiovasc Res. 2012;95(3):265-268.
24. Wehrens XH. CaMKII regulation of the cardiac ryanodine receptor and sarcoplasmic reticulum calcium release. Heart Rhythm. 2011;8(2):323-325.
25. Alkadhi KA, Alzoubi KH, Aleisa AM. Plasticity of synaptic transmission in autonomic ganglia. Prog Neurobiol. 2005;75(2):83-108.
26. Skold K, et al. Decreased striatal levels of PEP-19 following MPTP lesion in the mouse. J Proteome Res. 2006;5(2):262-269.
27. Utal AK, Stopka AL, Roy M, Coleman PD. PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease. Neuroscience. 1998;86(4):1055-1063.
28. Iwamoto K, Bundo M, Yamamoto M, Ozawa H, Saito T, Kato T. Decreased expression of NEFH and PCP4/PEP19 in the prefrontal cortex of alcoholics. Neurosci Res. 2004;49(4):379-385.
29. Kiriazis H, et al. Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease. J Physiol. 2012;590(pt 22):5845-5860.
30. Gutstein DE, et al. Conduction slowing and sudden arrhythmic death in mice with cardiacrestricted inactivation of connexin43. Circ Res. 2001;88(3):333-339.
31. Madisen L, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13(1):133-140.
32. Wei P, Blundon JA, Rong Y, Zakharenko SS, Morgan JI. Impaired locomotor learning and altered cerebellar synaptic plasticity in pep-19/PCP4- null mice. Mol Cell Biol. 2011;31(14):2838-2844.
33. Qu J, et al. Gap junction remodeling and spironolactone-dependent reverse remodeling in the hypertrophied heart. Circ Res. 2009;104(3):365-371.
34. Mori J, et al. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: A metabolic contribution to heart failure with normal ejection fraction. Circ Heart Fail. 2012;5(4):493-503.
35. Sotoodehnia N, et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet. 2010;42(12):1068-1076.
36. Ram R, Mickelsen DM, Theodoropoulos C, Blaxall BC. New approaches in small animal echocardiography: imaging the sounds of silence. Am J Physiol Heart Circ Physiol. 2011;301(5):H1765-H1780.
37. Cerrone M, et al. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res. 2005;96(10):e77-e82.
38. Thireau J, Zhang BL, Poisson D, Babuty D. Heart rate variability in mice: A theoretical and practical guide. Exp Physiol. 2008;93(1):83-94.